FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application by Mylan Pharmaceuticals to market a generic fixed-dose combination of perphenazine and amitriptyline hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (perphenazine and amitriptyline hydrochloride)

Snippet

SUPPL AP for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE)